In MDS, one study showed a correlation between TET2 mutations and a more favorable prognosis, while other studies showed no impact of TET2 mutations on the prognosis in MDS and AML (153–155) or even an inverse correlation (156). This evidence concerns the gene TET2 and myelodysplastic syndrome.